Predicted to enable identical protein binding activity and oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor. Predicted to be involved in cellular detoxification of aldehyde and fructosamine catabolic process. Predicted to be located in cytosol. Is expressed in liver; metanephros; ovary; testis; and urogenital ridge. Orthologous to human ALDH1A1 (aldehyde dehydrogenase 1 family member A1). [provided by Alliance of Genome Resources, Apr 2022]